{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:35:28Z","timestamp":1766748928846},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.2515\/therapie:2005090","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T05:45:14Z","timestamp":1173764714000},"page":"603-605","source":"Crossref","is-referenced-by-count":9,"title":["La trim\u00e9tazidine \u2013 nouvelle \u00e9tiologie de troubles extrapyramidaux : un cas de syndrome parkinsonien avec akathisie"],"prefix":"10.1016","volume":"60","author":[{"given":"Kamel","family":"Masmoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras-Champel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Douadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Andr\u00e9jak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2005090_bb1205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.revmed.2005.02.004","article-title":"Troubles extrapyramidaux sous v\u00e9ralipride (Agr\u00e9al\u00ae), traitement symptomatique des bouff\u00e9es de chaleur : \u00e0 propos de 17 cas","volume":"26","author":"Masmoudi","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.2515\/therapie:2005090_bb1210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2515\/therapie:2004021","article-title":"Les syndromes parkinsoniens m\u00e9dicamenteux","volume":"59","author":"Nguyen","year":"2004","journal-title":"Therapie"},{"key":"10.2515\/therapie:2005090_bb1215","first-page":"392","article-title":"Parkinsonismo por trimetazidina","volume":"19","author":"Marti-Masso","year":"2004","journal-title":"Neurologia"},{"key":"10.2515\/therapie:2005090_bb1220","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/mds.20574","article-title":"Trimetazidine: a new cause for drug-induced parkinsonism?","volume":"20","author":"Sommet","year":"2005","journal-title":"Mov Disord"},{"key":"10.2515\/therapie:2005090_bb1225","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments : actualisation de la m\u00e9thode utilis\u00e9e en France","volume":"40","author":"Begaud","year":"1995","journal-title":"Therapie"},{"key":"10.2515\/therapie:2005090_bb1230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2515\/therapie:2005061","article-title":"Trimetazidine induced parkinsonism gait disorders and tremor","volume":"60","author":"Marti-Masso","year":"2005","journal-title":"Therapie"},{"key":"10.2515\/therapie:2005090_bb1235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00002826-199510000-00004","article-title":"Effects of calcium antagonists on the dopamine system","volume":"18","author":"Mena","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.2515\/therapie:2005090_bb1240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/jcbfm.1995.63","article-title":"D2 receptor blockade by fluarizine and cinnarizine explains extrapyramidal side effects. A SPECT study","volume":"15","author":"Brucke","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.2515\/therapie:2005090_bb1245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mds.870120119","article-title":"A long-term follow-up study of cinnarizinne- and flunarizine-induced parkinsonism","volume":"12","author":"Negrotti","year":"1997","journal-title":"Mov Disord"},{"key":"10.2515\/therapie:2005090_bb1250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2003.12.004","article-title":"Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis","volume":"10","author":"Teive","year":"2004","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716303511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T02:58:19Z","timestamp":1554260299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716303511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0040595716303511"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2005090","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}